AU7568794A - Hiv (vif)-related compositions, and prophylactic and therapeutic uses thereof - Google Patents

Hiv (vif)-related compositions, and prophylactic and therapeutic uses thereof

Info

Publication number
AU7568794A
AU7568794A AU75687/94A AU7568794A AU7568794A AU 7568794 A AU7568794 A AU 7568794A AU 75687/94 A AU75687/94 A AU 75687/94A AU 7568794 A AU7568794 A AU 7568794A AU 7568794 A AU7568794 A AU 7568794A
Authority
AU
Australia
Prior art keywords
vif
hiv
prophylactic
therapeutic uses
related compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75687/94A
Inventor
Mary Jane Potash
David J Volsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Lukes Roosevelt Hospital Center
Original Assignee
ST LUKE S ROOSEVELT HOSPITAL C
St Lukes Roosevelt Hospital Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ST LUKE S ROOSEVELT HOSPITAL C, St Lukes Roosevelt Hospital Center filed Critical ST LUKE S ROOSEVELT HOSPITAL C
Publication of AU7568794A publication Critical patent/AU7568794A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU75687/94A 1993-08-20 1994-08-19 Hiv (vif)-related compositions, and prophylactic and therapeutic uses thereof Abandoned AU7568794A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11022693A 1993-08-20 1993-08-20
US110226 1993-08-20
PCT/US1994/009313 WO1995005851A1 (en) 1993-08-20 1994-08-19 HIV vif-RELATED COMPOSITIONS, AND PROPHYLACTIC AND THERAPEUTIC USES THEREOF

Publications (1)

Publication Number Publication Date
AU7568794A true AU7568794A (en) 1995-03-21

Family

ID=22331893

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75687/94A Abandoned AU7568794A (en) 1993-08-20 1994-08-19 Hiv (vif)-related compositions, and prophylactic and therapeutic uses thereof

Country Status (2)

Country Link
AU (1) AU7568794A (en)
WO (1) WO1995005851A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6776986B1 (en) 1996-06-06 2004-08-17 Novartis Ag Inhibition of HIV-1 replication by antisense RNA expression
JP4418101B2 (en) * 1997-09-18 2010-02-17 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア Attenuated vifDNA immunization cassette for genetic vaccines
CN1339320A (en) * 2000-08-18 2002-03-13 清华大学 AIDS vacuum and its preparing method and use
ATE343591T1 (en) 2001-04-06 2006-11-15 Univ Jefferson ANTAGONIST FOR MULTIMERIZATION OF HIV-1 VIF PROTEIN
EP1629003B1 (en) 2003-05-23 2008-03-12 Oregon Health & Science University Methods for identifying inhibitors
US20050222068A1 (en) 2003-10-23 2005-10-06 Mourich Dan V Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells
US8158770B2 (en) 2004-05-06 2012-04-17 University Of Rochester Content dependent inhibitors of cytidine deaminases and uses thereof
EP2376633A1 (en) 2008-12-17 2011-10-19 AVI BioPharma, Inc. Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2752788B2 (en) * 1989-01-23 1998-05-18 カイロン コーポレイション Recombinant therapy for infection and hyperproliferative disorders
DE69033311T2 (en) * 1989-06-02 2000-02-17 Institut National De La Sante Et De La Recherche Medicale I.N.S.E.R.M., Paris Nucleotide sequences of the genome of retroviruses of the HIV-1, HIV-2 and SIV types, their uses for the amplification of these genomes and the in vitro diagnosis of these viral infections
FR2647809B1 (en) * 1989-06-02 1991-09-20 Pasteur Institut OLIGONUCLEOTIDE PRIMERS FOR THE AMPLIFICATION OF THE GENOME OF HIV-1, HIV-2 AND SIV RETROVIRUSES AND THEIR APPLICATIONS TO IN VITRO DIAGNOSIS OF INFECTIONS DUE TO THESE VIRUSES
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus

Also Published As

Publication number Publication date
WO1995005851A1 (en) 1995-03-02

Similar Documents

Publication Publication Date Title
AU7564694A (en) Erection-inducing methods and compositions
AU7323294A (en) Perfluoroelastomeric compositions and methods
AU8123294A (en) Electrical initiator
AU7207094A (en) Wrist brace
AU7138394A (en) N,n-diacylpiperazines
AU5494294A (en) Hop extract and use thereof
AU8074694A (en) Keyboard
AU1248395A (en) Bandages
AU5794094A (en) Tricritical point composition
AU9075591A (en) N-halochitosans, their preparation and uses
AU4167493A (en) Polyfluorohydrocarbon group-containing acrylates, their polymers and applications of the polymers
AU5505794A (en) Alkali-treated bagasse, and its preparation and uses
AU7796494A (en) Compositions including two hydrofluorocarbons
AU7957794A (en) Anti-allergic, anti-inflammatory compounds, compositions and uses
AU7320894A (en) Red powder articles, compositions and methods
NZ250863A (en) Pseudopeptides, preparation and antiviral compositions
AU5798996A (en) Adnaz, compositions and processes
AU7568794A (en) Hiv (vif)-related compositions, and prophylactic and therapeutic uses thereof
AU5922694A (en) 2-amino-4-quinolyl-dihydropyridines, processes for their preparation, and their use
AU1441195A (en) Phenylmethyl hexanamides, and the use thereof
AU7741394A (en) High tear strength silicone compositions
AU5773994A (en) Cable-making compositions
AU6511294A (en) Tonometer
AU3286993A (en) Explosive composition, manufacture and use thereof
AU6242494A (en) Slip resistant compositions and uses